PFE
Pfizer
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: PFE
- PEG Ratio
PFE's PEG ratio cannot be computed because the earnings growth data is negative or zero. Historical data from September 2025 shows Pfizer with a PEG ratio of 0.11.
PFE PEG ratio history
Pfizer's ten years historical PEG ratio averages out to 0.53. PFE hit its maximum PEG ratio of 6.26 during the Dec 2016 quarter over the last ten years. The Mar 2025 quarter marked the lowest reading at 0.01, indicating the most attractive growth-adjusted valuation.
Pfizer PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | N/A | 18.18 | -3.5% |
| 2024 | 0.07 | 18.68 | 273.7% |
| 2023 | N/A | 75.76 | -93.2% |
| 2022 | 0.22 | 9.17 | 42.6% |
| 2021 | 0.11 | 15.06 | 137.6% |
| 2020 | N/A | 22.31 | -42.7% |
| 2019 | 0.26 | 13.6 | 51.6% |
| 2018 | N/A | 22.97 | -46.8% |
| 2017 | 0.05 | 10.15 | 202.5% |
| 2016 | 6.26 | 27.53 | 4.4% |
| 2015 | N/A | 28.57 | -21.5% |
| 2014 | N/A | 21.63 | -55.4% |
| 2013 | 0.15 | 9.48 | 64.8% |
| 2012 | 0.24 | 12.8 | 53.1% |
| 2011 | 0.7 | 16.91 | 24.3% |
Pfizer PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | N/A | 20.64 | -5.8% |
| Dec 2025 | N/A | 18.18 | -3.5% |
| Sep 2025 | 0.11 | 13.81 | 126.3% |
| Jun 2025 | 0.02 | 12.8 | 520% |
| Mar 2025 | 0.01 | 18.14 | 2,880% |
| Dec 2024 | 0.07 | 18.68 | 273.7% |
| Sep 2024 | N/A | 38.28 | -58.9% |
| Jun 2024 | N/A | N/A | -111.8% |
| Mar 2024 | N/A | N/A | -101% |
| Dec 2023 | N/A | 75.76 | -93.2% |
| Oct 2023 | N/A | 17.93 | -65.2% |
| Jul 2023 | N/A | 9.63 | -27% |
| Apr 2023 | 0.48 | 7.89 | 16.4% |
| Dec 2022 | 0.22 | 9.17 | 42.6% |
| Oct 2022 | 0.15 | 8.24 | 53.5% |
PFE average PEG ratio chart
PEG comparison
PFE EPS growth
PFE Price vs fair value
PFE PEG vs peers
| Stock name | PEG ratio | Market cap |
|---|---|---|
| LLY ELI LILLY & Co | 0.3 | $1.04T |
| BMY Bristol Myers Squibb Co | 0.46 | $111.7B |
| AMGN Amgen Inc | 0.77 | $186.05B |
| AZN Astrazeneca plc | 0.78 | $273.29B |
| NVS Novartis AG | 2.31 | $284.17B |
| MRK Merck & Co Inc | N/A | $285.22B |
| JNJ Johnson & Johnson | N/A | $556.77B |
| ABT Abbott Laboratories | N/A | $152.98B |
| PFE Pfizer Inc | N/A | $142.94B |
Frequently asked questions
What is Pfizer's PEG ratio?
PFE's PEG ratio cannot be computed because EPS growth data is negative or not present.
What is the 5-year average PEG ratio for Pfizer (PFE)?
PFE shows a 5-year average PEG ratio of 0.13.
What is the highest PEG ratio for PFE?
PFE's PEG ratio topped out at 6.26 during the Dec 2016 quarter - the highest in ten years.
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.